AAAAAA

   
Results: 1-21 |
Results: 21
THE SELECTIVITY OF MDL-74,721 IN MODELS OF NEUROGENIC VERSUS VASCULARCOMPONENTS OF MIGRAINE
Authors: PETTY MA ELANDS J JOHNSON MP LINNIK MD HAMEL E MOSKOWITZ MA LEE WS MCCARTY DR HIBERT M BARON BM
Citation: Ma. Petty et al., THE SELECTIVITY OF MDL-74,721 IN MODELS OF NEUROGENIC VERSUS VASCULARCOMPONENTS OF MIGRAINE, European journal of pharmacology, 336(2-3), 1997, pp. 127-136
PHARMACOLOGICAL CHARACTERIZATION OF MDL-105,519, AN NMDA RECEPTOR GLYCINE SITE ANTAGONIST
Authors: BARON BM HARRISON BL KEHNE JH SCHMIDT CJ VANGIERSBERGEN PLM WHITE HS SIEGEL BW SENYAH Y MCCLOSKEY TC FADAYEL GM TAYLOR VL MURAWSKY MK NYCE P SALITURO FG
Citation: Bm. Baron et al., PHARMACOLOGICAL CHARACTERIZATION OF MDL-105,519, AN NMDA RECEPTOR GLYCINE SITE ANTAGONIST, European journal of pharmacology, 323(2-3), 1997, pp. 181-192
THE RECEPTOR-BINDING PROFILE OF MDL-100,907
Authors: VANGIERSBERGEN PLM BARON BM ELANDS J JOHNSON MP SORENSEN SM
Citation: Plm. Vangiersbergen et al., THE RECEPTOR-BINDING PROFILE OF MDL-100,907, Schizophrenia research, 18(2-3), 1996, pp. 4-4
ADMINISTRATION OF A COMPETITIVE NMDA ANTAGONIST MDL-100,453 REDUCES INFARCT SIZE AFTER PERMANENT MIDDLE CEREBRAL-ARTERY OCCLUSION IN RAT
Authors: JIANG N ZHANG RL BARON BM CHOPP M
Citation: N. Jiang et al., ADMINISTRATION OF A COMPETITIVE NMDA ANTAGONIST MDL-100,453 REDUCES INFARCT SIZE AFTER PERMANENT MIDDLE CEREBRAL-ARTERY OCCLUSION IN RAT, Journal of the neurological sciences, 138(1-2), 1996, pp. 36-41
[H-3] MDL-105,519, A HIGH-AFFINITY RADIOLIGAND FOR THE N-METHYL-D-ASPARTATE RECEPTOR-ASSOCIATED GLYCINE RECOGNITION SITE
Authors: BARON BM SIEGEL BW HARRISON BL GROSS RS HAWES C TOWERS P
Citation: Bm. Baron et al., [H-3] MDL-105,519, A HIGH-AFFINITY RADIOLIGAND FOR THE N-METHYL-D-ASPARTATE RECEPTOR-ASSOCIATED GLYCINE RECOGNITION SITE, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 62-68
PRECLINICAL CHARACTERIZATION OF THE POTENTIAL OF THE PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100,907 AS A POTENT 5-HT2A ANTAGONIST WITH A FAVORABLE CNS SAFETY PROFILE
Authors: KEHNE JH BARON BM CARR AA CHANEY SF ELANDS J FELDMAN DJ FRANK RA VANGIERSBERGEN PLM MCCLOSKEY TC JOHNSON MP MCCARTY DR POIROT M SENYAH Y SIEGEL BW WIDMAIER C
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF THE POTENTIAL OF THE PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100,907 AS A POTENT 5-HT2A ANTAGONIST WITH A FAVORABLE CNS SAFETY PROFILE, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 968-981
BINDING OF THE RADIOLABELED GLYCINE SITE ANTAGONIST [H-3] MDL-105,519TO HOMOMERIC NMDA-NR1A RECEPTORS
Authors: SIEGEL BW SREEKRISHNA K BARON BM
Citation: Bw. Siegel et al., BINDING OF THE RADIOLABELED GLYCINE SITE ANTAGONIST [H-3] MDL-105,519TO HOMOMERIC NMDA-NR1A RECEPTORS, European journal of pharmacology, 312(3), 1996, pp. 357-365
ACTIVITIES OF NOVEL ARYLOXYALKYLIMIDAZOLINES ON RAT 5-HT2A AND 5-HT2CRECEPTORS
Authors: SIEGEL BW FREEDMAN J VAAL MJ BARON BM
Citation: Bw. Siegel et al., ACTIVITIES OF NOVEL ARYLOXYALKYLIMIDAZOLINES ON RAT 5-HT2A AND 5-HT2CRECEPTORS, European journal of pharmacology, 296(3), 1996, pp. 307-318
ANALYSIS OF (R)-4-OXO-5-PHOSPHONONORVALINE (MDL-100,453) IN RAT PLASMA AND BRAIN DIALYSATE USING LIQUID-CHROMATOGRAPHY AFTER DERIVATIZATIONWITH 6-AMINOQUINOLYL-N-HYDROXYSUCCINIMIDYL CARBAMATE
Authors: CORNELIUS KE FADAYEL GM BARON BM SCHMIDT CJ HAEGELE KD CHEN TM
Citation: Ke. Cornelius et al., ANALYSIS OF (R)-4-OXO-5-PHOSPHONONORVALINE (MDL-100,453) IN RAT PLASMA AND BRAIN DIALYSATE USING LIQUID-CHROMATOGRAPHY AFTER DERIVATIZATIONWITH 6-AMINOQUINOLYL-N-HYDROXYSUCCINIMIDYL CARBAMATE, Journal of pharmaceutical and biomedical analysis, 14(1-2), 1995, pp. 143-150
BINDING OF 5H-DIBENZO[A,D]CYCLOHEPTENE AND DIBENZ[B,F]OXEPIN ANALOGS OF CLOZAPINE TO DOPAMINE AND SEROTONIN RECEPTORS
Authors: PHILLIPS ST DEPAULIS T NEERGAARD JR BARON BM SIEGEL BW SEEMAN P VANTOL HHM GUAN HC SMITH HE
Citation: St. Phillips et al., BINDING OF 5H-DIBENZO[A,D]CYCLOHEPTENE AND DIBENZ[B,F]OXEPIN ANALOGS OF CLOZAPINE TO DOPAMINE AND SEROTONIN RECEPTORS, Journal of medicinal chemistry, 38(4), 1995, pp. 708-714
MDL-100,458 AND MDL-102,288 - 2 POTENT AND SELECTIVE GLYCINE RECEPTORANTAGONISTS WITH DIFFERENT FUNCTIONAL PROFILES
Authors: KEHNE JH BARON BM HARRISON BL MCCLOSKEY TC PALFREYMAN MG POIROT M SALITURO FG SIEGEL BW SLONE AL VANGIERSBERGEN PLM WHITE HS
Citation: Jh. Kehne et al., MDL-100,458 AND MDL-102,288 - 2 POTENT AND SELECTIVE GLYCINE RECEPTORANTAGONISTS WITH DIFFERENT FUNCTIONAL PROFILES, European journal of pharmacology, 284(1-2), 1995, pp. 109-118
ANTICONVULSANT ACTIVITY OF A NOVEL NMDA GLYCINE SITE ANTAGONIST, MDL-104,653, AGAINST KINDLED-INDUCED AND SOUND-INDUCED SEIZURES
Authors: CHAPMAN AG DURMULLER N HARRISON BL BARON BM PARVEZ N MELDRUM BS
Citation: Ag. Chapman et al., ANTICONVULSANT ACTIVITY OF A NOVEL NMDA GLYCINE SITE ANTAGONIST, MDL-104,653, AGAINST KINDLED-INDUCED AND SOUND-INDUCED SEIZURES, European journal of pharmacology, 274(1-3), 1995, pp. 83-88
ACTIVATION OF G(I) PROTEIN BY PEPTIDE STRUCTURES OF THE MUSCARINIC M(2) RECEPTOR 2ND INTRACELLULAR LOOP
Authors: MCCLUE SJ BARON BM HARRIS BA
Citation: Sj. Mcclue et al., ACTIVATION OF G(I) PROTEIN BY PEPTIDE STRUCTURES OF THE MUSCARINIC M(2) RECEPTOR 2ND INTRACELLULAR LOOP, European journal of pharmacology. Molecular pharmacology section, 267(2), 1994, pp. 185-193
THE COMPETITIVE NMDA ANTAGONIST MDL-100,453 REDUCES INFARCT SIZE AFTER EXPERIMENTAL STROKE
Authors: HASEGAWA Y FISHER M BARON BM METCALF G
Citation: Y. Hasegawa et al., THE COMPETITIVE NMDA ANTAGONIST MDL-100,453 REDUCES INFARCT SIZE AFTER EXPERIMENTAL STROKE, Stroke, 25(6), 1994, pp. 1241-1245
ENZYME-ACTIVATED ANTAGONISTS OF THE STRYCHNINE-INSENSITIVE GLYCINE NMDA RECEPTOR
Authors: SALITURO FG TOMLINSON RC BARON BM PALFREYMAN MG MCDONALD IA SCHMIDT W WU HQ GUIDETTI P SCHWARCZ R
Citation: Fg. Salituro et al., ENZYME-ACTIVATED ANTAGONISTS OF THE STRYCHNINE-INSENSITIVE GLYCINE NMDA RECEPTOR, Journal of medicinal chemistry, 37(3), 1994, pp. 334-336
BINDING OF 5H-DIBENZO[B,E][1,4]DIAZEPINE AND CHIRAL 5H-DIBENZO[A,D]CYCLOHEPTENE ANALOGS OF CLOZAPINE TO DOPAMINE AND SEROTONIN RECEPTORS
Authors: PHILLIPS ST DEPAULIS T BARON BM SIEGEL BW SEEMAN P VANTOL HHM GUAN HC SMITH HE
Citation: St. Phillips et al., BINDING OF 5H-DIBENZO[B,E][1,4]DIAZEPINE AND CHIRAL 5H-DIBENZO[A,D]CYCLOHEPTENE ANALOGS OF CLOZAPINE TO DOPAMINE AND SEROTONIN RECEPTORS, Journal of medicinal chemistry, 37(17), 1994, pp. 2686-2696
A NOVEL ADENYLYL CYCLASE-ACTIVATING SEROTONIN RECEPTOR (5-HT7) IMPLICATED IN THE REGULATION OF MAMMALIAN CIRCADIAN-RHYTHMS
Authors: LOVENBERG TW BARON BM DELECEA L MILLER JD PROSSER RA REA MA FOYE PE RACKE M SLONE AL SIEGEL BW DANIELSON PE SUTCLIFFE JG ERLANDER MG
Citation: Tw. Lovenberg et al., A NOVEL ADENYLYL CYCLASE-ACTIVATING SEROTONIN RECEPTOR (5-HT7) IMPLICATED IN THE REGULATION OF MAMMALIAN CIRCADIAN-RHYTHMS, Neuron, 11(3), 1993, pp. 449-458
MOLECULAR APPROACH TO HYPOTHALAMIC RHYTHMS - ISOLATION OF NOVEL INDOLEAMINE RECEPTOR GENES
Authors: ERLANDER MG LOVENBERG TW BARON BM DELECEA L SUTCLIFFE JG
Citation: Mg. Erlander et al., MOLECULAR APPROACH TO HYPOTHALAMIC RHYTHMS - ISOLATION OF NOVEL INDOLEAMINE RECEPTOR GENES, Journal of biological rhythms, 8, 1993, pp. 190000025-190000031
CLONING OF NEW 5-HT RECEPTORS
Authors: LOVENBERG TW ERLANDER MG BARON BM SUTCLIFFE JG
Citation: Tw. Lovenberg et al., CLONING OF NEW 5-HT RECEPTORS, International clinical psychopharmacology, 8, 1993, pp. 19-23
2 MEMBERS OF A DISTINCT SUBFAMILY OF 5-HYDROXYTRYPTAMINE RECEPTORS DIFFERENTIALLY EXPRESSED IN RAT-BRAIN
Authors: ERLANDER MG LOVENBERG TW BARON BM DELECEA L DANIELSON PE RACKE M SLONE AL SIEGEL BW FOYE PE CANNON K BURNS JE SUTCLIFFE JG
Citation: Mg. Erlander et al., 2 MEMBERS OF A DISTINCT SUBFAMILY OF 5-HYDROXYTRYPTAMINE RECEPTORS DIFFERENTIALLY EXPRESSED IN RAT-BRAIN, Proceedings of the National Academy of Sciences of the United Statesof America, 90(8), 1993, pp. 3452-3456
GLYCINE ANTAGONISTS AS POTENTIAL NOVEL ANXIOLYTIC AGENTS
Authors: KEHNE JH BARON BM HARRISON BL MCDONALD IA PALFREYMAN MG SALITURO FG MCCLOSKEY TC WHITE HS
Citation: Jh. Kehne et al., GLYCINE ANTAGONISTS AS POTENTIAL NOVEL ANXIOLYTIC AGENTS, Journal of neurochemistry, 61, 1993, pp. 190000051-190000051
Risultati: 1-21 |